[Classification and therapy of medication-overuse headache: impact of the third edition of the International Classification of Headache Disorders].
The diagnosis of medication-overuse headache (MOH) is of central importance because this secondary headache disorder can be treated very effectively and patients do not usually respond to headache prophylaxis as long as MOH persists. The article describes important changes in the diagnostic criteria of different MOH subtypes after publication of the International Classification of Headache Disorders (ICHD-3beta) in 2013. The new classification has a crucial and direct impact on prevention and treatment of MOH. In addition interactions exist with the new criteria of chronic migraine. With a controlled medication intake scheme according to the 10-20 rule and using a medication break, MOH usually remits in most patients. If patient education and advice does not lead to remission of MOH, a specialized managed medication break or withdrawal treatment becomes necessary. This can be done on an outpatient, day clinic or inpatient basis. In uncomplicated cases, the results of these three treatment settings do not differ. From a cost-effectiveness standpoint, the outpatient treatment should be given priority. In complicated cases, a fully inpatient withdrawal treatment using a multimodal treatment concept is significantly superior.
Migräne- und Kopfschmerzzentrum, Neurologisch-verhaltensmedizinische Schmerzklinik Kiel, Heikendorfer Weg 9-27, 24149, Kiel, Deutschland, hg@schmerzklinik.de.
H
H
Göbel
K
K
Heinze-Kuhn
I
I
Petersen
C
C
Göbel
A
A
Göbel
A
A
Heinze
D000553:Ambulatory Care; D000700:Analgesics / Q000008:administration & dosage / Q000009:adverse effects; D003131:Combined Modality Therapy; D003631:Day Care, Medical; D005858:Germany; D020773:Headache Disorders / Q000188:drug therapy*; D051271:Headache Disorders, Secondary / Q000145:classification* / Q000175:diagnosis / Q000628:therapy*; D006801:Humans; D038801:International Classification of Diseases; D008881:Migraine Disorders / Q000188:drug therapy*; D010343:Patient Admission; D010353:Patient Education as Topic; D013375:Substance Withdrawal Syndrome / Q000628:therapy
D000700:Analgesics